Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,781 shares at $455.06 ($1.3M) on 2025-02-18, disclosed to the SEC on 2025-02-19.
Scheduled sale ($1.3M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $463.46 | 2,293 | $1.1M | 82.7% |
| 2 | $455.06 | 244 | $111K | 8.6% |
| 3 | $455.06 | 244 | $111K | 8.6% |
| Total | $461.99 avg | 2,781 | $1.3M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |